Virtual Medicinal Product (VMP) - Glecaprevir 100mg / Pibrentasvir 40mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Glecaprevir 100mg / Pibrentasvir 40mg tablets | Start Date 14-08-2017 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AP57
- BNF Codes
-
- BNF code 05030302
| Code | Start Date | End Date |
|---|---|---|
| 34734811000001103 | 14-08-2017 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Glecaprevir | Based on Ingredient Substance | 100 mg | ||
| Pibrentasvir | Based on Ingredient Substance | 40 mg |
Name
Pibrentasvir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
40.0
Strength and UOM (Dmr)
Name
Glecaprevir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
Parent Products
-
VTMGlecaprevir + Pibrentasvir
-
VMP(Current) Glecaprevir 100mg / Pibrentasvir 40m...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 84 tablet |